Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan. 1, 2026, after ...

As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...

Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...

GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...

There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Oprah Opens Up About Obesity, GLP-1s and Her Healthy New Life: 'I've Never Felt Stronger'. In PEOPLE's new cover story, the ...

Shake Shack's Good Fit Menu puts a high-protein and gluten-free spin on the classics that are made with customers using GLP-1 ...